News | February 01, 2011

Court Rules for Volcano, Against St. Jude in OCT Trade Secrets Case

January 31, 2011 – Volcano Corp. said today the Superior Court of Massachusetts issued a decision ruling in favor of Volcano and its subsidiary Axsun Technologies Inc., and against LightLab Imaging Inc., on all of LightLab's remaining claims for intravascular optical coherence tomography (OCT) trade secret misappropriation. The 11-page decision also rejected LightLab's request for injunctive relief.

This ruling follows prior court rulings, in October 2010 and December 2009, that rejected LightLab's other trade secret misappropriation claims. LightLab Imaging is a wholly-owned subsidiary of St. Jude Medical Inc.

"We are pleased with this ruling. Along with prior court decisions issued in October 2010 and in December 2009, it confirms that that Volcano/Axsun are not using LightLab's purported trade secrets in our OCT development efforts. We intend to continue developing our OCT system, and can now do so with the reassurance that the court concurs with our position. Volcano will continue to execute on our growth strategy of providing industry leading diagnostic and therapeutic imaging devices to improve patient outcomes," said Scott Huennekens, president and CEO of Volcano.

Axsun manufactures OCT components for Lightlab’s intravascular OCT imaging system, which is the only OCT system cleared by U.S. Food and Drug Administration (FDA). St. Jude purchased LightLab in May 2010, shortly after the OCT system gained FDA clearance.

Volcano is also developing an OCT system, which it hopes will gain FDA clearance by mid-2011. The system is already cleared for use in Europe.

For more information: www.volcanocorp.com

Related Content

Avinger, Lightbox L250 imaging console, upgrade, Lumivascular platform, OCT, optical coherence tomography
Technology | Intravascular Imaging| January 11, 2017
January 11, 2017 — Avinger Inc. recently announced the U.S.
IVPA, intravascular photoacoustic imaging, fatty arteries, Purdue, Shanghai

IVPA/IVUS imaging of a perfused fresh human right coronary artery dissected from an explanted heart. (A) IVPA image. (B) IVUS image. (C) Merged IVPA/IVUS image. The 1 mm scale bar applies to all panels.

News | Intravascular Imaging| May 25, 2016
A new imaging system known as intravascular photoacoustic (IVPA) imaging that produces three-dimensional images of the...
PCI, OFDI, OCT, optical coherence tomography, optimal frequency domain imaging, EuroPCR 2016 study
News | Intravascular Imaging| May 20, 2016
Using optimal frequency domain imaging (OFDI) to guide percutaneous coronary intervention (PCI) with second-generation...
vulnerable plaques, OCT, IVUS, catheter, combination, NIBIB study

The dual catheter OCT-IVUS imaging device can be inserted into an artery to simultaneously capture an infrared image of the arterial wall (OCT, at left) and an ultrasound image (IVUS, right) that doctors use to determine the potential that a plaque is susceptible to rupture that could cause a heart attack or stroke.

News | Intravascular Imaging| May 12, 2016
May 12, 2016 — Collaboration between two National Institute of Biomedical Imaging and Bioengineering (NIBIB)-funded l
St. Jude Medical, Optis Mobile Sytem, Europe and Japan launch, OCT and angiography
Technology | Intravascular Imaging| February 08, 2016
St. Jude Medical Inc. announced the launch of the company’s Optis Mobile System in Japan and Europe. The diagnostic...
Videos | Intravascular Imaging| October 30, 2015
Ziad  Ali, M.D., associate director of translational medicine, Columbia University Medical Center / New York-Presbyte
Infraredx, NIRS, IVUS
News | Intravascular Imaging| September 11, 2015
September, 11, 2015 – Japanese medical vendor Nipro Corp.
Pie Medical Imaging, CAAS IntraVascular 2.0, OCT, IVUS, NIRS-IVUS
Technology | Intravascular Imaging| August 03, 2015
Pie Medical Imaging announced the release of CAAS IntraVascular 2.0, the dedicated software for analysis of...
St. Jude Medical, OCT, ILUMIEN III, IVUS, angiography, PCI
Feature | Intravascular Imaging| July 10, 2015
St. Jude Medical, Inc. announced the launch of the ILUMIEN III clinical trial on June 30. ILUMIEN III is a prospective...
Ilumien Optis, 3D OCT, 3-D OCT

An OCT 3-D reconstructed image of a coronary vessel cutaway showing a stent and bifurcating vessels.

Feature | Intravascular Imaging| July 02, 2015 | Dave Fornell
Angiography alone for procedural image guidance in the catheterization lab is sometimes not enough, and it is helpful...
Overlay Init